Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients

Background: Despite improvement of tumor response rates, targeted therapy may induce toxicities in cancer patients. Recent studies indicate amelioration of adverse events (AEs) by add-on mistletoe (Viscum album L., VA) in standard oncological treatment. The primary objective of this multicenter obse...

Descripción completa

Detalles Bibliográficos
Autores principales: Thronicke, Anja, Oei, Shiao Li, Merkle, Antje, Matthes, Harald, Schad, Friedemann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164814/
https://www.ncbi.nlm.nih.gov/pubmed/30200590
http://dx.doi.org/10.3390/medicines5030100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164814/
https://www.ncbi.nlm.nih.gov/pubmed/30200590
http://dx.doi.org/10.3390/medicines5030100

Ejemplares similares